HPV infection found to increase risk of lung cancer
the ONA take:
According to a new study published in the Journal of Clinical Virology, researchers have found that there is a strong association between lung tissue with human papillomavirus (HPV) infection, particularly HPV subtypes 16 and 18, and lung cancer. For the meta-analysis, the researchers searched various databases through March 2014 and identified nine studies that it total included 1,094 lung cancer cases and 484 non-cancer cases.
Statistical analyses showed that HPV infection was associated with lung cancer (Odds Ratio [OR] = 5.67, 95% CI: 3.09-10.40, P <0.001). Researchers also found that HPV subtypes 16 and 18 were similarly associated with lung cancer (OR = 6.02, 95% CI: 3.22-11.28, P <0.001). Furthermore, HPV 16 and 18 were strongly associated with lung squamous cell carcinoma (SCC) (OR = 9.78, 95% CI: 6.28-15.22, P <0.001), which was three times greater than with lung adenocarcinoma (OR = 3.69, 95% CI: 0.99-13.71, P = 0.052).
The findings suggest that HPV subtypes 16 and 18 infection significantly elevates the risk for developing SCC, indicating that there may be causal pathogenesis association between HPV and lung cancer.
Researchers have found that there is a strong association between lung tissue with HPV.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|